Literature DB >> 23619551

Methodological remarks concerning a recent meta-analysis on XPG Asp1104His and XPF Arg415Gln polymorphisms and breast cancer risk.

Qiliu Peng, Xianjun Lao, Ruoling Li, Xue Qin, Shan Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23619551     DOI： 10.1007/s10549-013-2526-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  3 in total

1.  Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.

Authors:  Kang Sun; Aixia Gong; Pin Liang
Journal:  Tumour Biol       Date:  2014-10-30

2.  Genetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancer.

Authors:  Weicai Hu; Jinbing Pan; Pu Zhao; Guangyu Yang; Shujuan Yang
Journal:  Tumour Biol       Date:  2014-03-11

3.  Association study between XPG Asp1104His polymorphism and colorectal cancer risk in a Chinese population.

Authors:  Haina Du; Xizhi Zhang; Mulong Du; Nannan Guo; Zhipeng Chen; Yongqian Shu; Zhengdong Zhang; Meilin Wang; Lingjun Zhu
Journal:  Sci Rep       Date:  2014-10-21       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.